Cargando…
Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681496/ https://www.ncbi.nlm.nih.gov/pubmed/31378200 http://dx.doi.org/10.1186/s13014-019-1324-y |
_version_ | 1783441740768739328 |
---|---|
author | Bao, Zhirong Wang, Dajiang Chen, Shupeng Chen, Min Jiang, Dazhen Yang, Chunxu Liu, Hui Dai, Jing Xie, Conghua |
author_facet | Bao, Zhirong Wang, Dajiang Chen, Shupeng Chen, Min Jiang, Dazhen Yang, Chunxu Liu, Hui Dai, Jing Xie, Conghua |
author_sort | Bao, Zhirong |
collection | PubMed |
description | BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC + LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). RESULTS: Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p < 0.05) in IMRT (BM) plans while the average volume receiving ≥20, ≥30, ≥40Gy decreased by 7.1–24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p < 0.05) in IMRT (OC + LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC + LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V(20) of OC and LS in the IMRT (OC + LS) plan decreased by 11.5 and 11.2%, respectively. CONCLUSION: By introducing the os coxae and lumbosacral spine as the dose–volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans. |
format | Online Article Text |
id | pubmed-6681496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66814962019-08-07 Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer Bao, Zhirong Wang, Dajiang Chen, Shupeng Chen, Min Jiang, Dazhen Yang, Chunxu Liu, Hui Dai, Jing Xie, Conghua Radiat Oncol Research BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC + LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). RESULTS: Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p < 0.05) in IMRT (BM) plans while the average volume receiving ≥20, ≥30, ≥40Gy decreased by 7.1–24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p < 0.05) in IMRT (OC + LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC + LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V(20) of OC and LS in the IMRT (OC + LS) plan decreased by 11.5 and 11.2%, respectively. CONCLUSION: By introducing the os coxae and lumbosacral spine as the dose–volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans. BioMed Central 2019-08-05 /pmc/articles/PMC6681496/ /pubmed/31378200 http://dx.doi.org/10.1186/s13014-019-1324-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bao, Zhirong Wang, Dajiang Chen, Shupeng Chen, Min Jiang, Dazhen Yang, Chunxu Liu, Hui Dai, Jing Xie, Conghua Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
title | Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
title_full | Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
title_fullStr | Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
title_full_unstemmed | Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
title_short | Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
title_sort | optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681496/ https://www.ncbi.nlm.nih.gov/pubmed/31378200 http://dx.doi.org/10.1186/s13014-019-1324-y |
work_keys_str_mv | AT baozhirong optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT wangdajiang optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT chenshupeng optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT chenmin optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT jiangdazhen optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT yangchunxu optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT liuhui optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT daijing optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer AT xieconghua optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer |